Exhibit A to Purchase Agreement REGISTRATION RIGHTS AGREEMENT Dated as of August 7, 1997 By and Between ICN PHARMACEUTICALS, INC.Registration Rights Agreement • August 14th, 1997 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTUREIndenture • August 14th, 1997 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New York
ICN PHARMACEUTICALS, INC. $275,000,000 Aggregate Principal Amount of 9 1/4% Senior Notes due 2005 PURCHASE AGREEMENTPurchase Agreement • August 14th, 1997 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
ANDIndenture • November 25th, 2003 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Exhibit 4.5 REGISTRATION RIGHTS AGREEMENT FOR SECURITIES REGISTRATION RIGHTS AGREEMENT FOR SECURITIES (the "Agreement"), dated as of October 9, 1996, by and among ICN Pharmaceuticals, Inc., a Delaware corporation (the "Company") and the Investors (as...Registration Rights Agreement • November 19th, 1996 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New York
ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this "Agreement") is made and entered into on October 30, 1997 by and between Roche Products Inc. a Panamanian corporation with offices at Calle Aquilino de la Guardia, No. 8, Edificio Igra,...Asset Purchase Agreement • May 17th, 1999 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New York
JANUARY 22, 2004 CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH "[CONFIDENTIAL TREATMENT]." AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE...Asset Purchase Agreement • May 10th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations
AMONGAssignment and Assumption Agreement • March 1st, 2007 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Agreement amongAgreement • March 31st, 2003 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSEmployment Agreement • March 31st, 2003 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.26 VALEANT PHARMACEUTICALS INTERNATIONAL $200,000,000 3.0% CONVERTIBLE SUBORDINATED NOTES DUE 2010 $200,000,000 4.0% CONVERTIBLE SUBORDINATED NOTES DUE 2013 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 25th, 2003 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENT THIS AGREEMENT entered into as of the 14th day of June, 1996 by and between ICN Pharmaceuticals, Inc. (the "Company"), and Dr. Devron Averett, an individual (the "Executive") (hereinafter collectively referred to as "the...Employment Agreement • March 31st, 1997 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
RECITALSEmployment Agreement • March 31st, 2003 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.41 EMPLOYMENT AGREEMENT THIS AGREEMENT entered into as of the 16th day of November, 2001, by and between ICN Pharmaceuticals, Inc. (the "Company") and Roger D. Loomis Jr., an individual (the "Executive") (hereinafter collectively referred...Employment Agreement • March 27th, 2002 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
EMPLOYMENT AGREEMENT THIS AGREEMENT entered into as of the 31 day of December, 1998, by and between ICN Pharmaceuticals, Inc. (the "Company") and Richard A. Meier, an individual (the "Executive") (hereinafter collectively referred to as "the...Employment Agreement • March 31st, 1999 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.8 AMENDED AND RESTATED DIASTAT ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 10th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
AMENDMENT TO EMPLOYMENT AGREEMENT AMENDMENT TO EMPLOYMENT AGREEMENT dated as of September 6, 1995 ("Amendment"), between ICN PHARMACEUTICALS, INC., a Delaware corporation (which, together with its subsidiaries and predecessors is referred to herein as...Employment Agreement • March 29th, 1996 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
AGREEMENTConfidentiality Agreement • November 2nd, 2001 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
RECITALSEmployment Agreement • March 15th, 2004 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
Exhibit 4.4 SALE AND PURCHASE AGREEMENT --------------------------- This Agreement is made on this 18 th day of September, 1996 by and between ORGANON TEKNIKA CORPORATION, a Delaware corporation having its principal place of business at 100 Akzo...Sale and Purchase Agreement • October 2nd, 1996 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSMerger Agreement • February 2nd, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 EXECUTIVE SEVERANCE AGREEMENT THIS AGREEMENT by and between VALEANT PHARMACEUTICALS INTERNATIONAL, a Delaware corporation (the "Company"), and Eileen C. Pruette (the "Executive") is made as of April 22, 2005, 2005 (the "Effective Date")....Executive Severance Agreement • April 27th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
RECITALSEmployment Agreement • March 27th, 2002 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 4.6 STOCK SUBSCRIPTION AGREEMENT AMONG ICN PHARMACEUTICALS, INC. andStock Subscription Agreement • November 19th, 1996 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.5 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 9th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
FORM OF EXECUTIVE SEVERANCE AGREEMENTExecutive Severance Agreement • June 17th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
RECITALSClosing Agreement • March 31st, 2003 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 1.1 7,200,000 Shares of Common Stock VALEANT PHARMACEUTICALS INTERNATIONAL UNDERWRITING AGREEMENT February 3, 2005 BEAR, STEARNS & CO. INC. 383 Madison Avenue New York, New York 10179 Ladies/Gentlemen: Valeant Pharmaceuticals International, a...Underwriting Agreement • February 4th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Exhibit 4.1 AGREEMENT dated as of October 19, 2000 (this "Agreement") among ICN PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), and RELATIONAL INVESTORS, L.L.C., a Delaware limited liability company ("RILLC"), on behalf of itself and...Shareholder Agreement • April 30th, 2001 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
CREDIT AND GUARANTY AGREEMENT dated as of September 27, 2010 among VALEANT PHARMACEUTICALS INTERNATIONAL, as Borrower, BIOVAIL CORPORATION, as Parent and a Guarantor, CERTAIN SUBSIDIARIES OF VALEANT PHARMACEUTICALS INTERNATIONAL and BIOVAIL...Credit and Guaranty Agreement • October 1st, 2010 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
This CREDIT AND GUARANTY AGREEMENT, dated as of September 27, 2010, is entered into by and among VALEANT PHARMACEUTICALS INTERNATIONAL, a Delaware corporation (the “Borrower”), and, upon consummation of the Merger (as defined herein) and delivery of the Counterpart Agreement (as defined herein) pursuant to Section 5.16, BIOVAIL CORPORATION, a corporation continued under the federal laws of Canada (“Parent”), CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, and, upon consummation of the Merger (as defined herein) and delivery of the Counterpart Agreement (as defined herein) pursuant to Section 5.16, CERTAIN SUBSIDIARIES OF PARENT, as Guarantors, the Lenders party hereto from time to time, GOLDMAN SACHS LENDING PARTNERS LLC (“GSLP”), MORGAN STANLEY SENIOR FUNDING, INC. (“Morgan Stanley”) and JEFFERIES FINANCE LLC (“Jefferies”), as Joint Lead Arrangers, Joint Bookrunners and Syndication Agents (each of GSLP, Morgan Stanley and Jefferies in such capacities, “Syndication Agent”), GSLP,
SECOND AMENDMENT TO CREDIT AGREEMENT This Second Amendment to Credit Agreement is entered into this 24th day of February 1998, by and between BANQUE NATIONALE DE PARIS, Los Angeles Branch (the "Bank"), and ICN PHARMACEUTICALS, INC., a Delaware...Credit Agreement • March 31st, 1998 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 1.1 ICN PHARMACEUTICALS, INC. $200,000,000 AGGREGATE PRINCIPAL AMOUNT OF 8 3/4 % SENIOR NOTES DUE 2008 PURCHASE AGREEMENTPurchase Agreement • September 18th, 1998 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
PREAMBLEExecutive Employment Agreement • March 31st, 2003 • Icn Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.32 **CERTAIN CONFIDENTIAL MATERIAL CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO 17 C.F.R. SUBSECTION 200.80(B)(4), 200.83 AND 240.24B-2.** AMENDMENT TO EXCLUSIVE...Exclusive License and Supply Agreement • November 2nd, 2001 • Icn Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSExecutive Employment Agreement • March 25th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
